Data / Drug companies / Shandong Xinhua Pharmaceutical Company Limited
Shandong Xinhua Pharmaceutical Company Limited: 63 products in the FDA NDC directory, labeler code 58624
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Shandong Xinhua Pharmaceutical Company Limited (labeler code 58624) lists 63 products in the FDA National Drug Code Directory, covering 2 finished drugs by generic name. By type: 51 bulk ingredients, 10 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on January 19, 2026.
The request: Watch Shandong Xinhua Pharmaceutical Company Limited (FDA labeler code 58624): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 58624
- Products in commercial distribution
- 63
- Packages
- 70
- Finished drugs by generic name
- 2
- Prescription products
- 1
- Over the counter products
- 1
- Controlled substance products
- Schedule IV 2
- Flagged as original packager
- 2 of 2 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- October 1, 1983
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 51 | 81% |
| Drugs for further processing | 10 | 15.9% |
| Generic drugs (ANDA) | 1 | 1.6% |
| Over the counter monograph drugs | 1 | 1.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 51 | 81% |
| Drugs for further processing | 10 | 15.9% |
| Prescription drugs | 1 | 1.6% |
| Over the counter drugs | 1 | 1.6% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Sevelamer carbonate | 1 | 35 |
| Calcium polycarbophil | 1 | 33 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 48 | 76.2% |
| Tablet, film coated | 8 | 12.7% |
| Tablet, coated | 4 | 6.3% |
| Liquid | 2 | 3.2% |
| Poultice | 1 | 1.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Phosphate Binder | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Theophylline anhydrous | 58624-0713 | Powder | Bulk ingredients | January 19, 2026 |
| Ibuprofen | 58624-6004 | Tablet, coated | Drugs for further processing | February 28, 2025 |
| Sevelamer carbonate | 58624-5001 | Tablet, film coated | Generic drugs (ANDA) | February 27, 2025 |
| Omega-3-acid ethyl esters | 58624-0712 | Liquid | Bulk ingredients | August 26, 2024 |
| Bismuth subsalicylate | 58624-0711 | Powder | Bulk ingredients | August 22, 2024 |
| Hydrocortisone acetate | 58624-0710 | Powder | Bulk ingredients | May 9, 2024 |
| Sevelamer carbonate | 58624-0709 | Powder | Bulk ingredients | May 9, 2024 |
| Glimepiride | 58624-0708 | Powder | Bulk ingredients | May 9, 2024 |
| Metamizole sodium monohydrate | 58624-0707 | Powder | Bulk ingredients | March 28, 2024 |
| Calcium Polycarbophil | 58624-5003 | Tablet, film coated | Over the counter monograph drugs | April 12, 2023 |
| Ibuprofen | 58624-7006 | Tablet, film coated | Drugs for further processing | June 16, 2021 |
| Ibuprofen | 58624-7005 | Tablet, film coated | Drugs for further processing | June 16, 2021 |
| Ibuprofen | 58624-7004 | Tablet, film coated | Drugs for further processing | June 16, 2021 |
| Ibuprofen | 58624-7003 | Tablet, film coated | Drugs for further processing | June 16, 2021 |
| Ibuprofen | 58624-7002 | Tablet, film coated | Drugs for further processing | June 16, 2021 |
| Ibuprofen | 58624-7001 | Tablet, film coated | Drugs for further processing | June 16, 2021 |
| Ethyl icosapentate | 58624-0411 | Liquid | Bulk ingredients | May 24, 2021 |
| Ibuprofen | 58624-6003 | Tablet, coated | Drugs for further processing | October 5, 2020 |
| Ibuprofen | 58624-6002 | Tablet, coated | Drugs for further processing | October 5, 2020 |
| Ibuprofen | 58624-6001 | Tablet, coated | Drugs for further processing | October 5, 2020 |
| Ibuprofen sodium | 58624-0536 | Powder | Bulk ingredients | June 11, 2010 |
| Nimodipine | 58624-0495 | Powder | Bulk ingredients | April 7, 2008 |
| Antipyrine | 58624-0620 | Powder | Bulk ingredients | January 1, 2008 |
| Meloxicam | 58624-0430 | Powder | Bulk ingredients | January 1, 2007 |
| Tramadol hydrochloride | 58624-0201 | Powder | Bulk ingredients | January 1, 2003 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.